Minneapolis, MN, United States of America

Ernesto Rubin Resnik

This inventor holds 1 USPTO granted patent. Top assignee: Bio-Techne Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernesto Rubin Resnik. Retrieved from https://idiyas.com/inventor/ernesto-rubin-resnik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernesto Rubin Resnik

Introduction

Ernesto Rubin Resnik is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for combating severe acute respiratory syndrome coronavirus.

Latest Patents

Ernesto holds a patent for "Anti-Severe Acute Respiratory Syndrome Coronavirus Antibodies." This innovative work showcases his dedication to addressing critical health challenges through scientific research and development. He has 1 patent to his name, reflecting his impactful contributions to the field.

Career Highlights

Ernesto is currently associated with Bio-Techne Corporation, where he applies his expertise in biotechnology to advance medical research and product development. His work at Bio-Techne has positioned him as a key player in the industry, contributing to the development of solutions that enhance health outcomes.

Conclusion

Ernesto Rubin Resnik's innovative work in biotechnology, particularly in developing antibodies for coronavirus, highlights his commitment to improving public health. His contributions are vital in the ongoing fight against infectious diseases, and his career continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…